rosiglitazone has been researched along with Anoxemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Cai-Yun, W; Jia, C; Jie-Feng, H; Ning-Fang, L; Qi-Chang, L; Yong-Xu, J | 1 |
| Chen, J; Chen, XQ; Hu, MY; Lei, FY; Qin, XK; Qin, YH; Wei, JS; Wei, JY | 1 |
| Guo, ZF; He, WX; Huang, SQ; Huang, YJ; Jiang, LL; Li, B; Li, CJ; Li, SH; Song, XW; Su, T; Wu, H; Zhang, BL | 1 |
| Bijli, KM; Carthan, KA; Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, KK; Searles, CD; Sutliff, RL; Yeligar, SM | 1 |
| Green, DE; Hart, CM; Kang, BY; Murphy, TC; Searles, CD | 1 |
| Bijli, KM; Blum, JI; Hart, CM; Kleinhenz, JM; Murphy, TC | 1 |
| Choi, JW; Kim, AY; Kim, JB; Kim, M; Lee, YS; Masuzaki, H; Park, KS; Son, HJ; Yasue, S | 1 |
| Bland, JM; Hart, CM; Kleinhenz, DJ; Mitchell, PO; Nisbet, RE; Sutliff, RL; Walp, ER | 1 |
| Crossno, JT; Garat, CV; Klemm, DJ; Reusch, JE; Sullivan, TM | 1 |
| Kim, EK; Lee, JH; Lee, SD; Lee, YS; Oh, YM | 1 |
| Hart, CM; Lu, X; Murphy, TC; Nanes, MS | 1 |
| Ambalavanan, N; Bulger, A; Chen, YF; Halloran, B; James, ML; Nicola, T; Olave, N; Oparil, S; Rehan, V; Zhang, W | 1 |
| Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC | 1 |
| Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N | 1 |
| Abdallah, BM; Abildtrup, L; Ebbesen, P; Fink, T; Fogd, K; Kassem, M; Zachar, V | 1 |
| Crossno, JT; Dempsey, EC; Garat, CV; Klemm, DJ; McMurtry, IF; Morris, KG; Reusch, JE; Stenmark, KR | 1 |
16 other study(ies) available for rosiglitazone and Anoxemia
| Article | Year |
|---|---|
The role of PPARγ in intermittent hypoxia-related human umbilical vein endothelial cell injury.
Topics: Apoptosis; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Sleep Apnea, Obstructive | 2023 |
Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Epithelial Cells; Hypoglycemic Agents; Hypoxia; Kidney; Male; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2022 |
Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG.
Topics: AMP-Activated Protein Kinases; Apoptosis; DNA Methylation; Heart Failure; Humans; Hypoxia; In Situ Hybridization, Fluorescence; Myocardial Ischemia; Myocytes, Cardiac; PPAR gamma; RNA, Long Noncoding; Rosiglitazone | 2023 |
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Topics: 3' Untranslated Regions; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; PPAR gamma; Pulmonary Artery; Pyrroles; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection; Vascular Remodeling | 2016 |
PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.
Topics: Animals; Cell Proliferation; Gene Expression; Gene Expression Regulation; Humans; Hypoxia; Ligands; Male; Mice; MicroRNAs; Myocytes, Smooth Muscle; PPAR gamma; PTEN Phosphohydrolase; Pulmonary Artery; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1 | 2015 |
Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.
Topics: Cell Proliferation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ligands; Myocytes, Smooth Muscle; PPAR gamma; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2016 |
Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress.
Topics: 3T3-L1 Cells; Acetylcysteine; Adipose Tissue; Animals; Antioxidants; Base Sequence; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Humans; Hypoxia; Kidney; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidative Stress; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.
Topics: Animals; Blood Pressure; Cell Proliferation; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypoxia; Ligands; Male; Mice; NADPH Oxidase 4; NADPH Oxidases; Organ Size; PPAR gamma; PTEN Phosphohydrolase; Receptor, Platelet-Derived Growth Factor beta; Rosiglitazone; Signal Transduction; Superoxides; Thiazolidinediones; Vasodilator Agents | 2010 |
Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
Topics: Animals; Becaplermin; Blotting, Western; Casein Kinase II; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cytosol; Hypertension, Pulmonary; Hypoxia; Male; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR alpha; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Rats; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2010 |
Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats.
Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Male; PPAR gamma; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factors | 2010 |
PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.
Topics: Animals; Cell Proliferation; Cells, Cultured; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Hypoxia; Mice; Myocytes, Smooth Muscle; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Oxygen; PPAR gamma; Promoter Regions, Genetic; Pulmonary Artery; Reactive Oxygen Species; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2010 |
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
Topics: Airway Remodeling; Animals; Animals, Newborn; Antibodies, Neutralizing; Chronic Disease; Collagen; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice; Mice, Inbred C57BL; PPAR gamma; Pulmonary Alveoli; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.
Topics: Animals; Aspartic Acid Endopeptidases; Cell Hypoxia; Cell Proliferation; Endothelial Cells; Endothelin-1; Endothelin-Converting Enzymes; Gene Expression; Gene Expression Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; NF-kappa B; PPAR gamma; Pulmonary Artery; Receptor, Endothelin A; Receptor, Endothelin B; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2011 |
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation | 2012 |
Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia.
Topics: Adipocytes; Azo Compounds; Blotting, Western; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line; Cytoplasm; DNA-Binding Proteins; Flow Cytometry; Gene Expression; Humans; Hypoxia; Lipid Metabolism; Lipoprotein Lipase; Mesenchymal Stem Cells; Microscopy, Fluorescence; Oxazines; Oxygen; Phenotype; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones; Time Factors; Transcription Factors; Transcription, Genetic | 2004 |
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.
Topics: Animals; Blood Pressure; Collagen; Elastin; Extracellular Matrix; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; PPAR gamma; Proto-Oncogene Proteins c-kit; Pulmonary Artery; Rats; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones | 2007 |